NL7216281A - - Google Patents

Info

Publication number
NL7216281A
NL7216281A NL7216281A NL7216281A NL7216281A NL 7216281 A NL7216281 A NL 7216281A NL 7216281 A NL7216281 A NL 7216281A NL 7216281 A NL7216281 A NL 7216281A NL 7216281 A NL7216281 A NL 7216281A
Authority
NL
Netherlands
Application number
NL7216281A
Other versions
NL150101B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7216281A publication Critical patent/NL7216281A/xx
Publication of NL150101B publication Critical patent/NL150101B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
NL727216281A 1971-12-14 1972-11-30 Werkwijze voor het bereiden van 3-aryloxy-2-hydroxypropylaminen met (beta)-adrenergisch blokkerende werking; werkwijze ter bereiding van (beta)-adrenergisch blokkerende farmaceutische preparaten, alsmede de aldus verkregen gevormde voortbrengselen. NL150101B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00207954A US3857891A (en) 1971-12-14 1971-12-14 New aminoalkanol compounds and methods for their production

Publications (2)

Publication Number Publication Date
NL7216281A true NL7216281A (es) 1973-06-18
NL150101B NL150101B (nl) 1976-07-15

Family

ID=22772656

Family Applications (1)

Application Number Title Priority Date Filing Date
NL727216281A NL150101B (nl) 1971-12-14 1972-11-30 Werkwijze voor het bereiden van 3-aryloxy-2-hydroxypropylaminen met (beta)-adrenergisch blokkerende werking; werkwijze ter bereiding van (beta)-adrenergisch blokkerende farmaceutische preparaten, alsmede de aldus verkregen gevormde voortbrengselen.

Country Status (21)

Country Link
US (1) US3857891A (es)
JP (1) JPS5233621B2 (es)
AR (2) AR195896A1 (es)
AT (1) AT317182B (es)
AU (1) AU475446B2 (es)
BE (1) BE790165A (es)
CA (1) CA993889A (es)
CH (1) CH551371A (es)
DK (1) DK134906B (es)
ES (1) ES409565A1 (es)
FI (1) FI55650C (es)
FR (1) FR2163486B1 (es)
GB (1) GB1344976A (es)
HU (1) HU164953B (es)
IE (1) IE37701B1 (es)
IL (1) IL40833A (es)
NL (1) NL150101B (es)
NO (1) NO135244C (es)
SE (1) SE393104B (es)
YU (2) YU35871B (es)
ZA (1) ZA727078B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2119843B1 (es) * 1970-12-28 1974-03-22 Laroche Navarro Labo
JPS5653534B2 (es) * 1973-10-25 1981-12-19
SE388849B (sv) * 1974-02-14 1976-10-18 Haessle Ab Forfarande for framstellning av nya aminer med beta-receptorstimulerande verkan
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
US4080471A (en) * 1976-06-25 1978-03-21 Aktiebolaget Hassle Use of substituted isopropylaminopropanols for inducing inotropic effects of the human heart
JPS56158868A (en) * 1980-05-13 1981-12-07 Satake Eng Co Ltd Ion nitriding treatment device
NZ211815A (en) * 1984-05-15 1988-11-29 Warner Lambert Co Preparation of 1-((3,4-dimethoxyphenethyl)amino)-3- (3-tolyloxy)-2-propanol
US5095151A (en) * 1985-05-21 1992-03-10 American Home Products Corporation Preparation of propranolol hydrochloride macrocrystals
US4789751A (en) * 1985-10-01 1988-12-06 University Patents, Inc. Synthesis of new liquid crystal materials possessing phenylbenzoate or biphenyl core units and (2,3)-epoalkyloxirane methanol chiral tails
JP2587336B2 (ja) * 1991-10-03 1997-03-05 日本ケミファ株式会社 塩酸ベバントロールの製造方法
US5482964A (en) * 1994-10-11 1996-01-09 Warner-Lambert Company Substituted phenoxyhydroxypropyl amines as central nervous system agents
TW467881B (en) * 1997-07-31 2001-12-11 Ying-Jiun Chen Guaiacoxypropanolamines with Α/β-adrenergic blocking activity
WO2000005193A1 (en) * 1998-07-23 2000-02-03 Chen Ing Jun GUAIACOXYPROPANOLAMINE DERIVATIVES WITH α/β-ADRENERGIC BLOCKING ACTIVITY
AP2005003232A0 (en) 2002-08-19 2005-03-31 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
GEP20084406B (en) 2003-05-30 2008-06-25 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as hmg-co inhibitors
CN1884251B (zh) * 2005-06-22 2010-06-23 北京德众万全医药科技有限公司 一种盐酸贝凡洛尔的精制方法
AU2006313430B2 (en) 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
KR102254542B1 (ko) * 2013-06-19 2021-05-24 솜 이노베이션 바이오테크, 에스.엘. 과다운동성 운동 장애의 예방 및/또는 치료에 사용하기 위한 치료제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL300886A (es) * 1962-11-23
NL301580A (es) * 1962-12-11
GB1069343A (en) * 1963-09-10 1967-05-17 Ici Ltd Propanolamine derivatives

Also Published As

Publication number Publication date
NO135244C (es) 1977-03-09
JPS5233621B2 (es) 1977-08-30
IE37701L (en) 1973-05-14
GB1344976A (en) 1974-01-23
FI55650B (fi) 1979-05-31
IL40833A (en) 1976-01-30
AU475446B2 (en) 1976-08-26
YU293979A (en) 1981-04-30
FR2163486A1 (es) 1973-07-27
HU164953B (es) 1974-05-28
DE2259489A1 (de) 1973-07-05
SE393104B (sv) 1977-05-02
YU301972A (en) 1981-02-28
DE2259489B2 (de) 1976-02-26
US3857891A (en) 1974-12-31
AU4918672A (en) 1974-05-23
YU35871B (en) 1981-08-31
AR195896A1 (es) 1973-11-15
NO135244B (es) 1976-11-29
AT317182B (de) 1974-08-12
DK134906B (da) 1977-02-07
FI55650C (fi) 1979-09-10
ZA727078B (en) 1973-06-27
CH551371A (fr) 1974-07-15
IL40833A0 (en) 1973-01-30
AR198442A1 (es) 1974-06-21
JPS4867232A (es) 1973-09-13
NL150101B (nl) 1976-07-15
DK134906C (es) 1977-06-27
CA993889A (en) 1976-07-27
ES409565A1 (es) 1975-12-01
BE790165A (fr) 1973-02-15
YU36007B (en) 1981-11-13
FR2163486B1 (es) 1976-03-05
IE37701B1 (en) 1977-09-28

Similar Documents

Publication Publication Date Title
ATA136472A (es)
AU2658571A (es)
AU2691671A (es)
AU2485671A (es)
AU3005371A (es)
AU2952271A (es)
AU2941471A (es)
AU2894671A (es)
AU2742671A (es)
AU2684071A (es)
AU2564071A (es)
AU2473671A (es)
AU2399971A (es)
AU3038671A (es)
AU2486471A (es)
AU3025871A (es)
AU2503871A (es)
AU2456871A (es)
AU2577671A (es)
AU2588771A (es)
AU2654071A (es)
AU2455871A (es)
AU2669471A (es)
AU2415871A (es)
AU2684171A (es)

Legal Events

Date Code Title Description
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: PARKE

V4 Discontinued because of reaching the maximum lifetime of a patent